LuminX Biotech

LuminX Biotech

Specializes in preclinical development platforms for cell therapies.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

$2.0m

Seed
Total Funding000k
Notes (0)
More about LuminX Biotech
Made with AI
Edit

LuminX Biotech specializes in providing advanced animal experimentation services, catering to both small and large animal studies. The company excels in cancer metastasis and tumor invasion research, offering the world's first quantitative technique for accurate tracking. LuminX also focuses on regenerative medicine, providing comprehensive services to accelerate experimental processes. Their expertise extends to immune cell tracking, ensuring precision in medical applications. LuminX offers customized experimental processes, understanding that a one-size-fits-all approach is not feasible. The company collaborates with government agencies, leveraging its technical expertise and unique materials for public sector projects. LuminX's business model revolves around offering specialized reagents and services, with a focus on planning suitable experimental methods for clients. The company operates in the biomedical research market, serving research institutions and government entities. Revenue is generated through the sale of customized experimentation services and reagents. Keywords: animal experimentation, cancer metastasis, regenerative medicine, immune cell tracking, customized experiments, biomedical research, government collaboration, precision medicine, quantitative techniques, reagent sales.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads